The outcome of patients with lupus nephritis and the impact of cardiovascular risk factors.

Drakoulogkona, O; Barbulescu, A L; Rica, I; Musetescu, A E; Ciurea, P L

Drakoulogkona, O; Barbulescu, A L; Rica, I; Musetescu, A E; Ciurea, P L.

Affiliation

Drakoulogkona O; Department of Nephrology, "St. Andrews" General State Hospital of Patras-Greece.
Barbulescu AL; Department of Rheumatology, University of Medicine and Pharmacy, Craiova.
Rica I; Department of Rheumatology, University of Medicine and Pharmacy, Craiova.
Musetescu AE; Department of Rheumatology, University of Medicine and Pharmacy, Craiova.
Ciurea PL; Department of Rheumatology, University of Medicine and Pharmacy, Craiova.

Curr Health Sci J ; 37(2): 70-4, 2011 Apr.

Article in En | MEDLINE | ID: mdl-24778833

Key words

anti phospholipid antibodies; cardiovascular risk factors; renal involvement; systemic lupus erythematosus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Curr Health Sci J Year: 2011 Document type: Article Country of publication: Romania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google